Literature DB >> 31070997

ApoB.

Allan D Sniderman1, Michael Pencina2, George Thanassoulis1.   

Abstract

Entities:  

Keywords:  apoB; atherosclerosis; cardiovascular disease; cholesterol; risk; triglycerides

Mesh：

Substances：

Year:  2019        PMID： 31070997     DOI： 10.1161/CIRCRESAHA.119.315019

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

1.  Integration of molecular profiles in a longitudinal wellness profiling cohort.

Authors:  Abdellah Tebani; Anders Gummesson; Wen Zhong; Ina Schuppe Koistinen; Tadepally Lakshmikanth; Lisa M Olsson; Fredrik Boulund; Maja Neiman; Hans Stenlund; Cecilia Hellström; Max J Karlsson; Muhammad Arif; Tea Dodig-Crnković; Adil Mardinoglu; Sunjae Lee; Cheng Zhang; Yang Chen; Axel Olin; Jaromir Mikes; Hanna Danielsson; Kalle von Feilitzen; Per-Anders Jansson; Oskar Angerås; Mikael Huss; Sanela Kjellqvist; Jacob Odeberg; Fredrik Edfors; Valentina Tremaroli; Björn Forsström; Jochen M Schwenk; Peter Nilsson; Thomas Moritz; Fredrik Bäckhed; Lars Engstrand; Petter Brodin; Göran Bergström; Mathias Uhlen; Linn Fagerberg
Journal:  Nat Commun       Date:  2020-09-08       Impact factor: 14.919

2.  Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships.

Authors:  Mika Ala-Korpela; Siyu Zhao; Marjo-Riitta Järvelin; Ville-Petteri Mäkinen; Pauli Ohukainen
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

3.  The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation.

Authors:  Lin-Zi Li; Hui-Ying Wang; Jia-Hui Huang; Kun Liu; Xiao-Jie Feng; Xi-Ming Wang; Li-Jie Zhu; Xing-Lishang He; Xiang Zheng; Hai-Long Li; Ying-Jie Dong; Bo Li; Han-Song Wu; Ning-Hua Jiang; Gui-Yuan Lv; Su-Hong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

4.  The Use of Blood Biomarkers in Precision Medicine for the Primary Prevention of Atherosclerotic Cardiovascular Disease: a Review.

Authors:  Ty Sweeney; Renato Quispe; Thomas Das; Stephen P Juraschek; Seth S Martin; Erin D Michos
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021-05-26

Review 5.  High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.

Authors:  Katharina Lechner; Amy L McKenzie; Nicolle Kränkel; Clemens Von Schacky; Nicolai Worm; Uwe Nixdorff; Benjamin Lechner; Johannes Scherr; Oliver Weingärtner; Ronald M Krauss
Journal:  Metab Syndr Relat Disord       Date:  2020-03-02       Impact factor: 1.894

6.  Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives.

Authors:  Tom G Richardson; Qin Wang; Eleanor Sanderson; Anubha Mahajan; Mark I McCarthy; Timothy M Frayling; Mika Ala-Korpela; Allan Sniderman; George Davey Smith; Michael V Holmes
Journal:  Lancet Healthy Longev       Date:  2021-05-21

7.  Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke.

Authors:  Shuai Yuan; Bowen Tang; Jie Zheng; Susanna C Larsson
Journal:  Ann Neurol       Date:  2020-10-10       Impact factor: 10.422

8.  Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.

Authors:  Tom G Richardson; Eleanor Sanderson; Tom M Palmer; Mika Ala-Korpela; Brian A Ference; George Davey Smith; Michael V Holmes
Journal:  PLoS Med       Date:  2020-03-23       Impact factor: 11.069
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.